Press release - 20/12/2010 Curcumin for the treatment of Alzheimer’s disease and cancer: healthy plant substances and their transport into the body Turmeric: Indians swear by the use of this yellow spice and believe in its healing power. In India, turmeric (curcumin) is believed to protect against cancer and help reduce the incidence of Alzheimer’s disease. Along with four academic and five industrial partners, Dr. Jan Frank from the University of Hohenheim is investigating how the effect of curcumin can be enhanced. The German Ministry of Education and Research is supporting the consortium…https://www.gesundheitsindustrie-bw.de/en/article/press-release/curcumin-for-the-treatment-of-alzheimer-s-disease-and-cancer-healthy-plant-substances-and-their-tran
Article - 20/12/2010 Michael Reth – Immunobiological discoveries that meet resistance Dr Michael Reth professor at the Max Planck Institute of Immunobiology and the University of Freiburg and some of his colleagues have recently uncovered the mechanism that foreign substances use to activate B cells of the immune system. The researchers were using synthetic biology methods long before this particular branch of science existed in its present form. Their results require a paradigm change and a revision of the reference books.https://www.gesundheitsindustrie-bw.de/en/article/news/michael-reth-immunobiological-discoveries-that-meet-resistance
Article - 20/12/2010 Invisible danger with long-term consequences According to official figures mycotoxins which are toxic secondary metabolites produced by moulds are found in around of 20 per cent of the European crop harvest. Even the smallest concentrations of mycotoxins can have devastating toxic effects causing cancer or posing a risk to fertility and development. Alexandra Heussner from the University of Konstanz is investigating ochratoxins whose chronic effect represents a huge danger to human health.https://www.gesundheitsindustrie-bw.de/en/article/news/invisible-danger-with-long-term-consequences
Article - 20/12/2010 Gicon: Using controllable biogas production to create virtual power stations Conventional biogas plants have the disadvantage that the production of energy cannot be controlled in a flexible way. Therefore, Großmann Ingenieur Consult GmbH (GICON) has developed a fast, simple method for controlling biogas production from renewable resources. In addition, the two-stage dry-wet fermentation process with split hydrolysis makes it possible to control the two stages independently. Heribert Krämer, head of the GICON subsidiary…https://www.gesundheitsindustrie-bw.de/en/article/news/gicon-using-controllable-biogas-production-to-create-virtual-power-stations
Article - 20/12/2010 ForCare – assessing the risks and benefits of environmental chemicals Over the last few years the EU has published a number of new guidelines stipulating thresholds for toxicologically relevant substances in food and other products. Some of these thresholds were implemented following a Greenpeace campaign relating to pesticides in food. The Freiburg-based Fachbüro für Toxikologie und nachhaltige Entwicklung Office for Toxicology and Sustainable Development ForCare played a part in the scientific studies behind this…https://www.gesundheitsindustrie-bw.de/en/article/news/forcare-assessing-the-risks-and-benefits-of-environmental-chemicals
Dossier - 20/12/2010 Environmental toxins: effect and origin Environmental toxins, also referred to as xenobiotics, are chemicals that do not occur in biological substance cycles; they are difficult to degrade and often have a toxic effect. Xenobiotic substances are becoming an increasing problem because we are constantly exposed to them and because they slowly but surely poison us. The World Health Organisation (WHO) sees xenobiotic substances as factors that contribute, along with other factors, to the…https://www.gesundheitsindustrie-bw.de/en/article/dossier/environmental-toxins-effect-and-origin
Press release - 18/12/2010 Gold for a construction kit full of viruses With a new strategy for the treatment of tumours, the team at the Freiburg Centre for Biological Signalling Studies (BIOSS) excellence cluster once again secured a top place in the international iGEM competition held by the Massachusetts Institute of Technology (MIT) in Cambridge, USA. https://www.gesundheitsindustrie-bw.de/en/article/press-release/gold-for-a-construction-kit-full-of-viruses
Press release - 14/12/2010 EU-funded research on genetically modified crops In order to help inform debate on genetically modified organisms, the European Commission is publishing a compendium entitled "A decade of EU-funded GMO research". The book summarizes the results of 50 research projects addressing primarily the safety of GMOs for the environment and for animal and human health. Launched between 2001 and 2010, these projects received funding of €200 million from the EU and form part of a 25-year long…https://www.gesundheitsindustrie-bw.de/en/article/press-release/eu-funded-research-on-genetically-modified-crops
Article - 13/12/2010 Christoph Kleineidam – communication without words Neuroethologist Dr. Christoph Kleineidam from the University of Konstanz focuses mainly on ants and their highly sensitive sensory system that allows them to communicate with each other by way of pheromones. He believes that these sensory mechanisms can be technologically implemented in the fields of thermosensor and chemosensor technology in the not-too-distant future.https://www.gesundheitsindustrie-bw.de/en/article/news/christoph-kleineidam-communication-without-words
Article - 12/12/2010 Pharmacovigilance: safety becomes a principle Tübingen-based CenTrial GmbH established in 2000 is a provider and manager of clinical trials. Pharmacovigilance is an important segment of the companys work CenTrial supports its clinical trial clients in all phases of clinical drug development related to drug safety up until the time a drug enters the market and beyond. The services offered range from the analysis of data to the complete design of the safety management process including…https://www.gesundheitsindustrie-bw.de/en/article/news/pharmacovigilance-safety-becomes-a-principle
Press release - 12/12/2010 Do adult stem cells contribute to healing and regeneration? The Baden-Württemberg Foundation is providing a total of 1.3 million euros in funding to two stem cell research projects from Ulm. The objective of the researchers working on these projects is to find out how adult stem cells can contribute to organ regeneration and wound healing. https://www.gesundheitsindustrie-bw.de/en/article/press-release/do-adult-stem-cells-contribute-to-healing-and-regeneration
Article - 11/12/2010 Opportunities, benefits and risks are not so different from each other Adverse drug reactions that compromise the safety of drugs do not necessarily mean that the development of a pharmaceutically active agent is immediately stopped. The case of a pharmaceutical agent initially developed by Tübingen-based c-a-i-r biosciences GmbH shows how an undesired event can actually lead to new opportunities. The original agent is now being further developed on a different basis from the original plans. https://www.gesundheitsindustrie-bw.de/en/article/news/opportunities-benefits-and-risks-are-not-so-different-from-each-other
Article - 09/12/2010 ‘Sniffer dogs’ working for the agrochemical industry As a chemistry student in the 1980s, Thomas Class focused on the investigation of environmental toxins such as dioxin and PCB under the supervision of Professor Karlheinz Ballschmiter. Back then, everybody was talking about the “environment”. The public as well as students and professors at the University of Ulm were all fascinated by the subject. Ulm University institutes were renamed to reflect this interest in the environment. While some of…https://www.gesundheitsindustrie-bw.de/en/article/news/sniffer-dogs-working-for-the-agrochemical-industry
Press release - 06/12/2010 Better imaging from bench to bedside Euro-BioImaging a project which launches its preparatory phase today aims to provide scientists throughout Europe with open access to state-of-the-art imaging technologies at all levels of biological and biomedical research from bench to bedside. The project is part of the European Commissions European Strategy Forum on Research Infrastructures ESFRI roadmap.https://www.gesundheitsindustrie-bw.de/en/article/press-release/better-imaging-from-bench-to-bedside
Article - 06/12/2010 Bioplastics – materials that have the potential to be used in medical technology At the recent International Symposium on Biopolymers ISBP in Stuttgart scientists discussed the use of biobased plastics for applications in the field of medical technology. The majority of strategies presented at the symposium will only be ready for market in a few years time. However they give an idea as to why bioplastics are likely to be applied to a greater extent in the field of medical technology.https://www.gesundheitsindustrie-bw.de/en/article/news/bioplastics-materials-that-have-the-potential-to-be-used-in-medical-technology
Press release - 06/12/2010 The taster in your water line Although drinking water is monitored more strictly than almost anything, our water supply network is still not immune to accidents, wear and tear or targeted attacks. A one-minute warning system for toxins and other substances in water hazardous to health could set off alarms in future if there is a danger.https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-taster-in-your-water-line
Press release - 06/12/2010 Kihara Foundation Kihara Memorial Yokohama Foundation for the Advancement of Life Sciences called Kihara Foundation was established in 1985 in memory of the late Dr. Hiroshi Kihara a world famous geneticist and evolutionary scientist Professor of Kyoto University for the advancement of Life Sciences.https://www.gesundheitsindustrie-bw.de/en/article/press-release/kihara-foundation
Press release - 05/12/2010 Baden-Württemberg ahead of all other German states in terms of health research Health research for the benefit of individuals is of great importance in Baden-Württemberg. Baden-Württemberg researchers are among the best in the field of health research both on a national and international level. This is reflected in the success achieved by universities research institutions and university hospitals in competitions said Minister President Stefan Mappus and Dr. Dietrich Birk Secretary of State in the Ministry of Science…https://www.gesundheitsindustrie-bw.de/en/article/press-release/baden-wuerttemberg-ahead-of-all-other-german-states-in-terms-of-health-research
Guest article - 05/12/2010 Report from Jiangsu Sandra Barudio a chemist from the University of Freiburg is currently doing four months practical training in the company GenePharma based in Suzhou Jiangsu province China. Barudio arrived in China at the beginning of September 2010 funded by a China grant from the Baden-Württemberg Ministry of Science Research and the Arts. She is a doctoral student in her second year at the Institute of Chemistry at Freiburg University and is doing her doctoral…https://www.gesundheitsindustrie-bw.de/en/article/news/report-from-jiangsu
Article - 03/12/2010 Review: Science meets Business Day 2010 (part I) Germinating seeds biosensors in the human body deaf people learning to hear again and new approaches to combat the flu virus the lectures held at the Science meets Business Day which concluded this years BioValley Science Week once again highlighted the innovations brought about through the joint efforts of research and industrial players on the Upper Rhine. https://www.gesundheitsindustrie-bw.de/en/article/news/review-science-meets-business-day-2010-part-i
Press release - 03/12/2010 Nanjing Medicinal Group Nanjing Medicinal group a state-owned enterprise is among the top six pharmaceutical conglomerates in China. It is composed of 15 pharmaceutical companies and controls 1000 retail drugstores. A hospital and a research institute are also part of the group.https://www.gesundheitsindustrie-bw.de/en/article/press-release/nanjing-medicinal-group
Article - 03/12/2010 Review: Science meets Business Day 2010 (part II) How can plant physiologists and seed developers work together to achieve an understanding of the processes happening in the germinating plant embryo in order to improve the seed quality of sugar beet? How can virologists find new ways to switch off the flu virus and develop a marketable vaccine in cooperation with industrial partners?https://www.gesundheitsindustrie-bw.de/en/article/news/review-science-meets-business-day-2010-part-ii
Article - 30/11/2010 Off-label use in children: the problem is known but improvement happens step by slow step The majority of drugs prescribed to children and adolescents have not been specifically licensed for their use. The majority of drugs have been tested and formulated for adults. This so-called off-label practice is associated with greater risks than those one would expect in medicinal therapy. We talked to Michael Kölch senior consultant in the Department of Paediatric and Adolescent PsychiatryPsychotherapy at Ulm University Hospital about this…https://www.gesundheitsindustrie-bw.de/en/article/news/off-label-use-in-children-the-problem-is-known-but-improvement-happens-step-by-slow-step
Article - 29/11/2010 Innovative 3D bioreactors for higher cell and tissue quality Two projects from Baden-Württemberg were among the winners of the 12th Medical Technology Innovation Competition organised by the German BMBF. One project consists of a new bioreactor technology developed at the Institute of Anatomy of the Centre for Regenerative Biology and Medicine (ZRM) in Tübingen, which seeks to improve the supply of cells and tissue with nutrients and oxygen by cultivating them in aerosols.https://www.gesundheitsindustrie-bw.de/en/article/news/innovative-3d-bioreactors-for-higher-cell-and-tissue-quality
Article - 29/11/2010 How axons find their way A group of researchers led by Prof. Dr. Martin Bastmeyer from the Institute of Zoology at the Karlsruhe Institute of Technology KIT is investigating how a complex network of molecular landmarks guides fully grown retinal axons to the correct point in the visual centre map. The researchers use chickens as model organism to simulate the mechanisms involved in axonal pathfinding and target recognition in cell cultures and computer simulations.https://www.gesundheitsindustrie-bw.de/en/article/news/how-axons-find-their-way